Half of people who get cancer are diagnosed late. Urine tests based on cancer biomarkers continues to be an area of research. Detecting at low concentration is one of the challenges. Here are a couple of recent reports.
- An enzyme test developed by a Canadian company, Biomark Diagnostics, has been able to successfully detect Stage One tumours in several cancers, including lung cancer.
- A media report about researchers at Brigham Young University finding a potentially novel way for early detection of prostate cancer and kidney disease. MicroRNAs (miRNAs) are biomarkers whose levels can be altered in disease states, such as prostate cancer and kidney disease. By attaching a nucleic acid receptors to microchannel surfaces, the researchers were able to measure the flow distance and correlate it with presence of biomarkers that indicate the presence of disease.